I have once again (as I did several months ago) moved my entire position in $MSOS into individual cannabis equities — preferring to identify those specific companies that will most likely benefit from a rescheduling of medical marijuana and adult recreational use.
This allows me to weight those companies as I see appropriate and not be subject to the decision of the MSOS manager — who has a portfolio that includes not only companies that may not survive but also some larger companies that I believe to be disadvantaged in the future.
Position: Long CURLD (S), TRVL (S), GTBIF (S), TSCNDF (S), VRNOD (M), GLASF (S)
Doug Kass is a world-renowned hedge fund manager with decades of experience and success navigating through some of the most turbulent periods in market history. He is known for his time-tested analytical skills and ability to look past the current noise and herd mentality.
On TheStreet Pro, Kass provides frequent market commentary and investing ideas for active investors throughout each trading day in Doug’s Daily Diary. He also serves as president of Seabreeze Partners Management Inc. Previously, he served as a senior manager at Omega Advisors, a $6 billion investment partnership. He co-authored a book with Ralph Nader and the Center for the Study of Responsive Law called “Citibank: The Ralph Nader Report” and can be found as a guest host on CNBC's "Squawk Box."
A Note from Doug: Current strategies and actionable trade ideas -- all on one dynamic platform built exclusively for active trades. From sudden sell-offs to sudden spikes, TheStreet Pro arms you with crucial analysis -- at a rapid fire, professional pace -- to help you make sound trading decisions -- every day, every hour, and every minute. Join me and my team of professional traders for unique perspectives and breakthrough investment opportunities.
